Levodolevodopa/Carbidopa/Entacapone Teva

Levodopa/Carbidopa/Entacapone, the active ingredient in Levodolevodopa/Carbidopa/Entacapone Teva, is a Levodopa/Carbidopa/Entacapone combination presented as a tablet (strength not specified) for oral use. It treats the motor symptoms of Parkinson's disease in adult patients. GNH USA supplies Levodolevodopa/Carbidopa/Entacapone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is used in the management of Parkinson's disease and related motor fluctuation pathways. - Parkinson's disease (motor fluctuations): reduces OFF periods and improves overall motor control. - Parkinson's disease (adjunct to levodopa): enhances central levodopa availability and prolongs its therapeutic effect. - Parkinson's disease (advanced stage): helps control symptoms when standard levodopa therapy alone is insufficient.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea - Vomiting - Orthostatic hypotension - Dizziness - Insomnia - Dyskinesia

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Severe hypertension or hypotension - Hallucinations or psychosis - Severe depression or suicidal thoughts - Hepatic dysfunction - Allergic skin reactions such as Stevens‑Johnson syndrome

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should consider several safety measures. - Monitor blood pressure: watch for orthostatic hypotension, especially at therapy initiation. - Assess psychiatric status: be alert for hallucinations, confusion, or mood changes. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: taper to prevent withdrawal symptoms. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levodopa/Carbidopa/Entacapone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: may exacerbate central side effects. - Iron or calcium supplements: reduce levodopa absorption if taken simultaneously.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: potential for serotonin syndrome. - Antihypertensive drugs: additive hypotensive effect. - Other COMT inhibitors: increased risk of toxicity.